Sanofi (EPA:SAN)

Market Cap	100.26B
Revenue (ttm)	45.17B
Net Income (ttm)	6.30B
Shares Out	1.22B
EPS (ttm)	5.04
PE Ratio	16.53
Forward PE	9.96
Dividend	3.92 (4.76%)
Ex-Dividend Date	May 12, 2025

Volume	1,900,878
Average Volume	2,096,479
Open	82.83
Previous Close	82.30
Day's Range	82.18 - 83.44
52-Week Range	82.10 - 110.88
Beta	0.40
RSI	31.30
Earnings Date	Jul 31, 2025

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; inf...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1994
• Employees: 82,878
• Stock Exchange: Euronext Paris
• Ticker Symbol: SAN

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.